Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
56 hedge funds and large institutions have $21M invested in Avid Bioservices, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 9 closing their positions.
228% more call options, than puts
Call options by funds: $262K | Put options by funds: $80K
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
20% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 15
6% more funds holding
Funds holding: 53 → 56 (+3)
21% less capital invested
Capital invested by funds: $26.5M → $21M (-$5.56M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$967K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$334K |
| 3 |
BP
Bandera Partners
New York
|
+$249K |
| 4 |
Goldman Sachs
New York
|
+$160K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$138K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Fondren Management
Houston,
Texas
|
-$644K |
| 2 |
AG
Algert Global
San Francisco,
California
|
-$426K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$323K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$310K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$219K |
CDMO Hedge Fund Activity: Q4 2017 in Review
56 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2017, worth a combined $21M — down 21% from $26.5M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CDMO positions and 9 closed out — a net gain of 4 holders — while 18 added to existing stakes and 15 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $967K. The largest seller was Fondren Management, exiting entirely with an estimated $644K sold.
- 56 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2017, up from 53 in Q3 2017.
- Funds reported $21M of Avid Bioservices, Inc. Common Stock stock for Q4 2017, down 21% quarter-over-quarter.
- 13 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2017 and 9 closed out, a net change of +4 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2017 was Geode Capital Management, an estimated $967K added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q4 2017 was Fondren Management, an estimated $644K sold.
Based on aggregated 13F filings for Q4 2017.